Telstar, the consulting, engineering and projects company for the pharmaceutical and biotechnology sector, is committed to providing financial support for ACE Foundation projects over the next three y...
Read moreGalecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company developing therapeutics that are designed to target the biological processes that lie at the heart of fibrosis and impact a broad r...
Read moreThe Barcelona Science Park (PCB), a Spain's leading scientific, technological and business innovation hub in the life sciences field, aims to embark on a new phase of growth, offering more than 1,200 ...
Read moreOncoheroes’ CEO, Ricardo Garcia, is attending Asebio Investor Day, a digital event organized by the “Asociación Española de Bioempresas“.
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported ...
Read moreOne of the basic processes of nature is the decomposition of organic matter, which requires the degradation of complex carbohydrate structures. To do so, it is necessary to break the long chains of...
Read moreThis month Sifted, the technology magazine of the Financial Times, has contacted various experts in the technology industry and in analyzing data on investments, has concluded that the Spanish entrepr...
Read moreThe UAB participates in the MER-CLUB initiative to develop a technology based on the use of marine bacteria capable of degrading a toxic mercury compound that bio-accumulates in the trophic network. T...
Read moreThe main event for the European biopharmaceutical sector is coming back to the city after its success here in 2010, 2013 and 2017
Read moreA study led by researchers at the Institute for Bioengineering of Catalonia (IBEC) opens the door to moving new microscopic objects using an entire library of enzymes.
Read moreMinoryx Therapeutics extends its activities in Belgium
Read moreIn June 2017, researchers from the IIB-Sant Pau, the Institute of Biotechnology and Biomedicine at the UAB and the CIBER-BBN, created a spin-off, Nanoligent, with the goal of developing the first drug...
Read more